Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol.
Janatani BalakumaranTanisha BirkBreanne GolemiecWryan HelmecziJeyanth InkaranYun-Ya KaoJennifer LeighSarah SalibaRishi SharmaLaura SpataforaKristin WrightWilliam YaoChristopher HillisLaura BanfieldLehana ThabaneUma AthaleM Constantine SamaanPublished in: BMJ open (2019)
CRD42018091175.